SCHEDULE 13GFiled Feb 16, 7:00 PM ET
MapLight Therapeutics, Inc. SCHEDULE 13G
Forbion Growth Opportunities Fund III Cooperatief U.A.Summary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.